Merit Medical Systems, Inc. (NASDAQ:MMSI) has earned a consensus rating of “Buy” from the fourteen brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $43.85.
Several equities analysts have recently issued reports on MMSI shares. ValuEngine upgraded Merit Medical Systems from a “hold” rating to a “buy” rating in a research report on Tuesday, November 21st. SunTrust Banks set a $47.00 price objective on Merit Medical Systems and gave the stock a “buy” rating in a research report on Thursday, November 16th. Zacks Investment Research upgraded Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 target price for the company in a research report on Saturday, October 28th. Canaccord Genuity upped their target price on Merit Medical Systems from $45.00 to $47.50 and gave the stock a “buy” rating in a research report on Thursday, October 26th. Finally, BidaskClub upgraded Merit Medical Systems from a “sell” rating to a “hold” rating in a research report on Thursday, January 18th.
Shares of Merit Medical Systems (NASDAQ MMSI) traded up $0.55 during midday trading on Friday, hitting $42.65. The stock had a trading volume of 257,115 shares, compared to its average volume of 271,676. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.43 and a current ratio of 2.78. The firm has a market capitalization of $2,176.12, a P/E ratio of 69.92, a PEG ratio of 2.58 and a beta of 1.29. Merit Medical Systems has a fifty-two week low of $27.25 and a fifty-two week high of $48.10.
Several hedge funds and other institutional investors have recently bought and sold shares of MMSI. Virtus Fund Advisers LLC bought a new position in shares of Merit Medical Systems in the fourth quarter valued at $160,000. Ameritas Investment Partners Inc. increased its holdings in shares of Merit Medical Systems by 20.9% in the second quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock valued at $163,000 after buying an additional 738 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of Merit Medical Systems in the third quarter valued at $189,000. Flinton Capital Management LLC increased its holdings in shares of Merit Medical Systems by 67.4% in the second quarter. Flinton Capital Management LLC now owns 5,236 shares of the medical instruments supplier’s stock valued at $200,000 after buying an additional 2,108 shares in the last quarter. Finally, Wolverine Trading LLC bought a new position in shares of Merit Medical Systems in the third quarter valued at $226,000. 87.98% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: This story was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at https://sportsperspectives.com/2018/02/10/merit-medical-systems-inc-mmsi-receives-43-85-average-price-target-from-analysts.html.
About Merit Medical Systems
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.